Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Penile Neoplasms 1Oropharyngeal Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Melanoma 1Head and Neck Neoplasms 1Colonic Neoplasms 1Castration Resistant Prostate Cancer 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1Anus Neoplasms 1

Interventions

Cyclophosphamide 7pembrolizumab 6fludarabine 6aldesleukin 4fludarabine phosphate 2entinostat 2Trastuzumab 2Radiotherapy 2Psychiatric Rehabilitation 2Nivolumab 2Interleukin-2 2Interleukin-12 Subunit p35 2Early Intervention, Educational 2Adoptive Transfer 2trastuzumab deruxtecan 1tislelizumab 1tipifarnib 1spartalizumab 1rocakinogene sifuplasmid 1oncogene protein E7, Human papillomavirus type 16 1enzalutamide 1durvalumab 1cemiplimab 1bintrafusp alfa protein, human 1atezolizumab 1alovudine 1abiraterone 1Vorinostat 1Vaccines, Synthetic 1VGX-3100 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anus Neoplasms × bintrafusp alfa protein, human × Genitourinary × Clear all
NCT04708470 2026-04-06

A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Active not recruiting
55 enrolled
GastrointestinalGenitourinaryGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡